A similar configuration with the CD8α transmembrane domain had anti-tumor activity that was comparable to 4-1BB/ICOS CAR-T cells with the 4-1BB domain in the proximal position and a CD8α transmembrane domain. The gene discussed is CD8A; the disease is neoplasm.